We aimed to assess the prevalence of hyperuricemia in a cohort of patients
with psoriatic arthritis (PsA) and to determine the influence of skin invol
vement on serum uric acid (SUA) levels. Patients followed at the University
of Toronto Psoriatic Arthritis clinic from 1991-1997 were studied. Those w
ho developed hyperuricemia (SUA >450 mu mol/L for males or >360 mu moI/L fo
r females) and the next 3 normouricemic PsA patients were studied. Skin inv
olvement was assessed using the Psoriasis Area and Severity index score. Of
265 patients, 55 (20.7%) had less than or equal to 1 episode of hyperurice
mia. There was no association between Psoriasis Area and Severity index sco
re and SUA. In multivariate analysis, the best predictors of hyperuricemia
were elevated serum creatinine and elevated total cholesterol. One or both
values were elevated in 70.9% of patients with hyperuricemia and 35.2% of c
ontrols (p < 0.001. SUA in PsA is not associated with the extent of skin in
volvement but reflects metabolic changes, especially hypercholesterolemia a
nd renal impairment.